Solubility enhancement of poorly soluble drugs

Solubility enhancement of poorly soluble drugs
Product Description

Amorphous Solid Dispersions via fluidbed granulation to achieve free flowing and direct compressible granules of the API in an amorphous form. This solution offers an optimized downstream process in comparision to the standard spray drying process.

Glatt Pharmaceutical Services supports the formulation and process development as well as the GMP manufacturing both for clininal and commercial.


We service our customers in our sites in USA (Ramsey) and Germany (Binzen)

Glatt Pharmaceutical Services GmbH & Co. K

  • DE
  • 2024
    On CPHI since
  • 2
    Certificates
  • 100 - 249
    Employees
Company types
CMO/CDMO
Consultancy
Primary activities
Animal Health
Contract Manufacturer
Laboratory Services
OTC
Specifications
  • Details
    Poorly soluble drugs are often optimized via spray drying processes which result in a fine powder and the need of further agglomeration before tableting.

    The approach of Glatt Pharmaceutical Services involves a spray granulation prociess via the fluid bed technology that can result in a free flowing and directly compressible granule with the API fixed in its amorphous state.
  • Selling Points
    Quality Service
  • Model
    Contract Development
  • Supplied from
    Germany; United States
  • Measured In
    Euro

Glatt Pharmaceutical Services GmbH & Co. K

  • DE
  • 2024
    On CPHI since
  • 2
    Certificates
  • 100 - 249
    Employees
Company types
CMO/CDMO
Consultancy
Primary activities
Animal Health
Contract Manufacturer
Laboratory Services
OTC

More Products from Glatt Pharmaceutical Services GmbH & Co. K (3)

  • Formulation Development

    Product Formulation Development

    Formulation & process development of complex oral solids drug products. Specialized in solubility enhancement, drug delivery, controlled release, functional coating, granulation, pellets & micropellets. From technical feasibility to GMP for clinical trials and commercial manufacturing.Core compente...
  • New Inert starter beads CELLETS® 150 by ingredientpharm

    Product New Inert starter beads CELLETS® 150 by ingredientpharm

    We introduce CELLETS® 150, a new particle size for our pharmaceutical MCC spheres, ranging from 150-300 µm. State-of-the-art formulations with modified release profiles are often based on API carriers such as MCC pellets. CELLETS® are 100% MCC starter beads, offering unbeaten stability, sphericity, and sur...
  • Paediatric Formulation Development

    Product Paediatric Formulation Development

    Glatt Pharmaceutical Services specializes in the development of pediatric formulations tailored to meet the specific needs of children. Recognizing that children require different dosage forms and strengths, Glatt focuses on creating age-appropriate, safe, and effective medications. Our expertise includes ...